Viridian Therapeutics, Inc.
NasdaqCM:VRDN
$ 14.58
+ $0.77 (5.58%)
$ 14.58
+ $0.77 (5.58%)
End-of-day quote: 05/02/2024

VRDN - Viridian Therapeutics Stock Prediction 2025 - 2030

7 years of reliable Viridian Therapeutics stock forecast. The Wall Street analysts predict Buy for VRDN. See at a glance whether NasdaqCM:VRDN will rise in the future.

$0.00
Forecast 2023
$17.41
Forecast 2025
$29.59
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$17.41
Forecast 2030
$29.59
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.1
Price-to-book Ratio
3.34
Market Cap
0.85B
TEV
0.97 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$40.21

Viridian Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Viridian Therapeutics Stock Forecast 2023

$37.50

In the last five quarters, Viridian Therapeutics’s Price Target has fallen from $44.16 to $40.21 - a -8.94% decrease. Nine analysts predict that Viridian Therapeutics’s share price will fall in the coming year, reaching $37.50. This would represent a decrease of -6.74%.

157.2%
157.2
Last update: 05/03/2024

Highest Price Target $46.00

Average Price Target $37.50

Lowest Price Target $30.00

Viridian Therapeutics Stock Forecast 2025

Stock Prediction for the Price of One Viridian Therapeutics Share in Jan 2025.

In Jan 2025 analysts predict a share price of $15.81. An increase of 8.41% compared to today's share price.

Stock Prediction for the Price of One Viridian Therapeutics Share in Feb 2025.

In Feb 2025 analysts predict a share price of $15.95. An increase of 9.41% compared to today's share price.

Stock Prediction for the Price of One Viridian Therapeutics Share in Mar 2025.

In Mar 2025 analysts predict a share price of $16.10. An increase of 10.41% compared to today's share price.

Stock Prediction for the Price of One Viridian Therapeutics Share in Apr 2025.

In Apr 2025 analysts predict a share price of $16.24. An increase of 11.41% compared to today's share price.

Stock Prediction for the Price of One Viridian Therapeutics Share in May 2025.

In May 2025 analysts predict a share price of $16.39. An increase of 12.41% compared to today's share price.

Stock Prediction for the Price of One Viridian Therapeutics Share in Jun 2025.

In Jun 2025 analysts predict a share price of $16.54. An increase of 13.41% compared to today's share price.

Stock Prediction for the Price of One Viridian Therapeutics Share in Jul 2025.

In Jul 2025 analysts predict a share price of $16.68. An increase of 14.42% compared to today's share price.

Stock Prediction for the Price of One Viridian Therapeutics Share in Aug 2025.

In Aug 2025 analysts predict a share price of $16.83. An increase of 15.42% compared to today's share price.

Stock Prediction for the Price of One Viridian Therapeutics Share in Sep 2025.

In Sep 2025 analysts predict a share price of $16.97. An increase of 16.42% compared to today's share price.

Stock Prediction for the Price of One Viridian Therapeutics Share in Oct 2025.

In Oct 2025 analysts predict a share price of $17.12. An increase of 17.42% compared to today's share price.

Stock Prediction for the Price of One Viridian Therapeutics Share in Nov 2025.

In Nov 2025 analysts predict a share price of $17.27. An increase of 18.42% compared to today's share price.

Stock Prediction for the Price of One Viridian Therapeutics Share in Dec 2025.

In Dec 2025 analysts predict a share price of $17.41. An increase of 19.42% compared to today's share price.

Viridian Therapeutics Stock Predictions 2030

Viridian Therapeutics Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $26.86. An increase of 84.24% compared to the previous month's estimate.

Viridian Therapeutics Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $27.11. An increase of 85.94% compared to the previous month's estimate.

Viridian Therapeutics Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $27.36. An increase of 87.64% compared to the previous month's estimate.

Viridian Therapeutics Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $27.61. An increase of 89.35% compared to the previous month's estimate.

Viridian Therapeutics Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $27.85. An increase of 91.05% compared to the previous month's estimate.

Viridian Therapeutics Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $28.10. An increase of 92.75% compared to the previous month's estimate.

Viridian Therapeutics Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $28.35. An increase of 94.45% compared to the previous month's estimate.

Viridian Therapeutics Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $28.60. An increase of 96.15% compared to the previous month's estimate.

Viridian Therapeutics Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $28.85. An increase of 97.86% compared to the previous month's estimate.

Viridian Therapeutics Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $29.10. An increase of 99.56% compared to the previous month's estimate.

Viridian Therapeutics Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $29.34. An increase of 101.26% compared to the previous month's estimate.

Viridian Therapeutics Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $29.59. An increase of 102.96% compared to the previous month's estimate.

P/E
0.00
Beta
1.1
Price-to-book Ratio
3.34
Market Cap
0.85B
TEV
0.97 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$40.21

Viridian Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Viridian Therapeutics, Inc.?

The following analysts have recently covered Viridian Therapeutics:

B. Riley Securities, Inc.
Evercore ISI
H.C. Wainwright & Co.
JMP Securities
Ladenburg Thalmann & Company
Leerink Partners LLC
LifeSci Capital, LLC
Needham & Company
Oppenheimer & Co. Inc.
RBC Capital Markets
Wedbush Securities Inc.
Wells Fargo Securities, LLC
Marktfeld
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Viridian Therapeutics, Inc.?

The following sell-side analysts have recently covered Viridian Therapeutics:

Patel, Kalpit R.
Clark-Gartner, Gavin
Tsao, Douglas Dylan
Butler, Jason Nicholas
Higgins, Michael John
Smith, Thomas Jonathan
Katkhuda, Rami Azeez
Belanger, Serge D.
Gershell, Leland James
Renza, Gregory James
Chico, Laura Kathryn
Archila, Derek Christian
Paraskevopoulos, Michail
(This information refers to the last 90 days.)